Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Biochemical Phenomena, Metabolism, and Nutrition (1)
- Cardiovascular Diseases (1)
- Chemicals and Drugs (1)
- Diseases (1)
- Hormones, Hormone Substitutes, and Hormone Antagonists (1)
-
- Life Sciences (1)
- Lipids (1)
- Medical Cell Biology (1)
- Medical Molecular Biology (1)
- Medical Nutrition (1)
- Medical Pharmacology (1)
- Medical Toxicology (1)
- Molecular, Genetic, and Biochemical Nutrition (1)
- Nutrition (1)
- Nutritional and Metabolic Diseases (1)
- Other Pharmacology, Toxicology and Environmental Health (1)
- Pharmacology, Toxicology and Environmental Health (1)
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Novel Role Of Cd47 In Obesity-Associated Metabolic Dysfunctions, Heather L. Norman-Burgdolf
Novel Role Of Cd47 In Obesity-Associated Metabolic Dysfunctions, Heather L. Norman-Burgdolf
Theses and Dissertations--Pharmacology and Nutritional Sciences
Obesity and its associated comorbidities are of global concern. These complications are largely driven by perturbations in energy homeostasis, inflammation, and oxidative stress within metabolic tissues. Although these underlying pathways have been established, molecular mechanisms augmenting metabolic dysfunction have not been fully defined. CD47, a ubiquitously expressed cell membrane receptor, has been previously implicated in the development of inflammation and oxidative stress in a number of disease conditions. Previous work from our lab and others has confirmed that the most potent ligand of CD47, TSP1, plays a critical role in facilitating inflammation and metabolic dysfunction in diet-induced obesity. Whether these …
The Role Of Pxr And Ikkβ Signaling In Cardiometabolic Disease, Robert N. Helsley
The Role Of Pxr And Ikkβ Signaling In Cardiometabolic Disease, Robert N. Helsley
Theses and Dissertations--Pharmacology and Nutritional Sciences
Cardiovascular disease (CVD) is the leading cause of death worldwide and is partially attributed to perturbations in lipid metabolism. Xenobiotics, such as pharmaceutical drugs and environmental chemicals, have been associated with increased risk of CVD in multiple large-scale human population studies, but the underlying mechanisms remain poorly defined. We and others have identified several xenobiotics as potent agonists for the pregnane X receptor (PXR), a nuclear receptor that can be activated by numerous drugs as well as environmental and dietary chemicals. However, the role of PXR in mediating the pathophysiological effects of xenobiotic exposure in humans and animals remains elusive. …